Exosomes from oxaliplatin‐resistant CRC cells transferred ciRS‐122 to oxaliplatin‐sensitive cells, enhancing glycolysis and drug resistance by promoting PKM2 expression. The gene discussed is PKM; the disease is colorectal carcinoma.